HLA genetic determinants in familial MS |
| |
Authors: | D. A. Francis J. R. Batchelor W. I. McDonald I. A. Dodi S. N. Hing J. E. C. Hern A. W. Downie |
| |
Affiliation: | Department of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, London;Institute of Neurology, National Hospital for Nervous Diseases, London, England;Department of Medicine, Aberdeen Royal Infirmary, Aberdeen, Scotland |
| |
Abstract: | ![]() Fourteen multiplex MS families, 9 single-case MS families and 11 normal families from the Grampian region of North-East Scotland were studied. The prevalence rate of MS for individuals in multiplex families was calculated at 809/100,000; 4.5 times the prevalence rate for the general population in this region. The distribution of shared haplotypes in 12 affected and 19 unaffected sib-pair comparisons did not differ significantly from that expected by chance. Furthermore there was no evidence that homozygosity of a particular HLA gene was required for increased susceptibility to the disease. HLA-B7, C4A3, C4B1, BfS, HLA-DR2, HLA-DQw1 was the commonest haplotype accounting for 18.9% and 24.2% of parental haplotypes from multiplex and single-case families, respectively, compared with 2.3% of parental haplotypes from control families (p less than 0.05 and p less than 0.01, respectively). No significant differences were observed in the frequencies of complement gene polymorphisms (Factor B and C4). The data suggests that a MS susceptibility gene exists, in the HLA complex, and is in closest linkage disequilibrium with the HLA-D region; although other factors, environmental and/or independent genetic loci, may have an important influence. |
| |
Keywords: | |
|
|